PROCEPT BioRobotics Corporation

Historical 13F Holders

Symbol
PRCT
CUSIP
74276L105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74276L105 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A Amendment 1 8.2% 7/29/2026
Event 6/30/2026
AllianceBernstein L.P. 13G/A Amendment 1 0.3% 5/18/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.0% 4/30/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 4 0% 3/27/2026
Event 3/13/2026
FMR LLC 13G/A Amendment 5
2.9% 3/6/2026
Event 2/27/2026
T. Rowe Price Investment Management, Inc. 13G 5.9% 2/17/2026
Event 12/31/2025
BNP Paribas Asset Management Holding S.A. 13G 5.5% 2/11/2026
Event 12/31/2025
FMR LLC 13G/A Amendment 4
8.3% 1/8/2026
Event 12/31/2025
AllianceBernstein L.P. 13G 6.1% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 22.4 k $409 k
2026 Q2 268 56.4 M $1.31 B
2026 Q1 272 55.9 M $1.40 B
2025 Q4 284 56.6 M $1.78 B
2025 Q3 266 58.4 M $2.09 B
2025 Q2 290 53.6 M $3.09 B
2025 Q1 301 50.5 M $2.94 B
2024 Q4 298 50.4 M $4.06 B
2024 Q3 272 46.6 M $3.72 B
2024 Q2 220 45.9 M $2.81 B
2024 Q1 179 46.9 M $2.31 B
2023 Q4 158 46.2 M $1.94 B
2023 Q3 134 44.5 M $1.46 B
2023 Q2 131 36.0 M $1.27 B
2023 Q1 125 33.1 M $941 M
2022 Q4 125 33.7 M $1.40 B
2022 Q3 109 33.7 M $1.40 B
2022 Q2 101 34.9 M $1.14 B
2022 Q1 60 31.0 M $1.09 B
2021 Q4 62 30.8 M $766 M
2021 Q3 59 27.2 M $1.03 B